Latest papers

A second corneal arcus?

Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.

Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study.

Analysis of Flavanols in Foods: What Methods are Required to Enable Meaningful Health Recommendations?

Blunted non-nitric oxide vasodilatory neurotransmission in penile arteries from renal hypertensive rats.

Comparison of the effect of diuretics on carotid blood flow in stroke patients.

Thiazide diuretic prescription and electrolyte abnormalities in primary care.

Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study.

[Antihypertensive therapy: campaign of the giants].

Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?

Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors.

Interaction of human serum albumin with bendroflumethiazide studied by fluorescence spectroscopy.

Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.

[Cardiac arrest following treatment with non-cardiologic QT-interval-increasing medications].

[Old or new antihypertensives--which are better?].

Differential cognitive outcomes in the Hypertensive Old People in Edinburgh study.

ASCOT blood pressure-lowering arm--study of effects of two BP-lowering regimens in hypertensive patients with cardiovascular risk factors.

Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.

ASCOT - blood pressure arm confirms efficacy of amlodipine/perindopril (Norvasc)/Coversyl) regimen.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.